MBA, President and CEO, iRhythm Technologies
Kevin M. King has served as iRhythm’s President, Chief Executive Officer and a member of the board of directors since July 2012. Mr. King has nearly three decades of experience in the healthcare and IT industries in leadership roles. Previously, he was President, Chief Executive Officer and a Director of Affymetrix, Inc., a publicly traded technology innovator in the field of genetic analysis. Prior to that, he served as President and Chief Executive Officer of Thomson Healthcare, an information services business which focused on a range of healthcare-related businesses. Mr. King was also a senior executive at GE Healthcare, where he led several business units including Magnetic Resonance Imaging and Global Clinical Systems Business. Mr. King began his career at HP’s Medical Products Group, holding leadership roles in Sales, Marketing, R&D, and Business Development. Mr. King has a B.A. in Economics and Biology from the University of Massachusetts and an M.B.A. from New Hampshire College.
Commercial Success to IPO: iRhythm CEO Interview
iRhythmn was the most successful diagnostic/digital health IPO of 2016. How does one build a >$600M commercial diagnostic company? Join us to hear about building operational excellence and the whirlwind path through clinical validation, FDA clearance, nationwide reimbursement, organization scaling, payments and contracting. Fireside chat with Kevin King, CEO.